Medicover Balance Sheet Health
Financial Health criteria checks 1/6
Medicover has a total shareholder equity of €541.0M and total debt of €607.3M, which brings its debt-to-equity ratio to 112.3%. Its total assets and total liabilities are €2.0B and €1.5B respectively. Medicover's EBIT is €70.6M making its interest coverage ratio 1.5. It has cash and short-term investments of €78.8M.
Key information
112.3%
Debt to equity ratio
€607.30m
Debt
| Interest coverage ratio | 1.5x |
| Cash | €78.80m |
| Equity | €541.00m |
| Total liabilities | €1.46b |
| Total assets | €2.00b |
Recent financial health updates
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Recent updates
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects
Apr 22Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes
Feb 16Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?
Dec 30Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)
Dec 17Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Oct 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?
Sep 09Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)
Jul 25Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Jul 12Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)
Jun 13At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?
May 29With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting
Apr 20Medicover (STO:MCOV B) Could Easily Take On More Debt
Apr 08Medicover (STO:MCOV B) Is Doing The Right Things To Multiply Its Share Price
Mar 15Is Now The Time To Look At Buying Medicover AB (publ) (STO:MCOV B)?
Feb 25Financial Position Analysis
Short Term Liabilities: MCOV B's short term assets (€393.7M) do not cover its short term liabilities (€521.9M).
Long Term Liabilities: MCOV B's short term assets (€393.7M) do not cover its long term liabilities (€934.7M).
Debt to Equity History and Analysis
Debt Level: MCOV B's net debt to equity ratio (97.7%) is considered high.
Reducing Debt: MCOV B's debt to equity ratio has increased from 45.6% to 112.3% over the past 5 years.
Debt Coverage: MCOV B's debt is well covered by operating cash flow (36.6%).
Interest Coverage: MCOV B's interest payments on its debt are not well covered by EBIT (1.5x coverage).